Allan Tillack

Generic and Biosimilar Medicines Industry Association (GBMA)

Chair of GBMA, Allan Tillack is also Country Head, Australia and New Zealand for Sandoz, where he leads the commercial Sandoz Australia and New Zealand business to drive mid and long term strategic business plans and sales strategies to increase market share and improve profitability. Spanning over 30 years, Allan’s previous industry experience includes positions in prescription pharmaceuticals for both brand pharma and generic companies, as well as the OTC market.